Rates of sustained virological response 12  weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?

ConclusionsWe found high SVR12 rates in monoinfected as well as coinfected individuals. No differences were detected between the two subgroups regardless of whether there was accompanying liver cirrhosis or a shortened treatment duration.

Source: HIV Medicine - January 25, 2018 Category: Infectious Diseases Authors: J Bischoff, S Mauss, C Cordes, T Lutz, S Scholten, A Moll, H J äger, M Cornberg, MP Manns, A Baumgarten, JK Rockstroh Tags: Original Research Source Type: research